We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+11.06%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.98%
AUM
$261B
AUM Growth
+$19.9B
Cap. Flow
-$3.39B
Cap. Flow %
-1.3%
Top 10 Hldgs %
22.36%
Holding
2,965
New
219
Increased
1,218
Reduced
1,020
Closed
126

Top Buys

Rank Stock Value
1
SHOP icon
Shopify
SHOP
+$873M
2
AAPL icon
Apple
AAPL
+$739M
3
ACN icon
Accenture
ACN
+$450M
4
IWS icon
iShares Russell Mid-Cap Value ETF
IWS
+$393M
5
CRM icon
Salesforce
CRM
+$359M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.39B
2
INFY icon
Infosys
INFY
+$641M
3
META icon
Meta Platforms (Facebook)
META
+$621M
4
JPM icon
JPMorgan Chase
JPM
+$483M
5
V icon
Visa
V
+$477M

Sector Composition

Rank Sector Weight
1 Technology 28.05%
2 Healthcare 12.84%
3 Consumer Discretionary 11.61%
4 Financials 11.34%
5 Communication Services 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRHC
2551
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$366K ﹤0.01%
24,377
CRIS icon
2552
Curis
CRIS
$7.83M
$363K ﹤0.01%
191
+56
+41% +$133K
PGEN icon
2553
Precigen
PGEN
$2.59B
$363K ﹤0.01%
97,850
VBIV
2554
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$363K ﹤0.01%
5,170
PGC icon
2555
Peapack-Gladstone Financial
PGC
$812M
$362K ﹤0.01%
10,225
NIC icon
2556
Nicolet Bankshares
NIC
$3.62B
$362K ﹤0.01%
+4,220
New +$322K
ME
2557
DELISTED
23andMe Holding Co
ME
$362K ﹤0.01%
+2,715
New +$501K
VERU icon
2558
Veru
VERU
$37.4M
$354K ﹤0.01%
6,006
+201
+3% +$15.4K
ANIP icon
2559
ANI Pharmaceuticals
ANIP
$1.78B
$351K ﹤0.01%
7,609
ORGO icon
2560
Organogenesis Holdings
ORGO
$239M
$349K ﹤0.01%
37,740
THFF icon
2561
First Financial Corp
THFF
$969M
$348K ﹤0.01%
7,693
-5,114
-40% -$225K
STEL
2562
DELISTED
Stellar Bancorp
STEL
$348K ﹤0.01%
+12,005
New +$339K
TBRG
2563
DELISTED
TruBridge
TBRG
$347K ﹤0.01%
11,849
TUR icon
2564
iShares MSCI Turkey ETF
TUR
$217M
$346K ﹤0.01%
18,601
TCS
2565
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$345K ﹤0.01%
2,303
-514
-18% -$86.8K
FMBH icon
2566
First Mid Bancshares
FMBH
$1.36B
$341K ﹤0.01%
7,972
GATO
2567
DELISTED
Gatos Silver, Inc.
GATO
$340K ﹤0.01%
+32,800
New +$394K
GERN icon
2568
Geron
GERN
$949M
$338K ﹤0.01%
276,819
RMO
2569
DELISTED
Romeo Power, Inc.
RMO
$338K ﹤0.01%
92,514
MOV icon
2570
Movado Group
MOV
$841M
$335K ﹤0.01%
+8,015
New +$303K
LXRX icon
2571
Lexicon Pharmaceuticals
LXRX
$1.1B
$330K ﹤0.01%
83,874
NGM
2572
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$330K ﹤0.01%
18,629
-6,316
-25% -$121K
RIDE
2573
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$329K ﹤0.01%
6,354
LOCO icon
2574
El Pollo Loco
LOCO
$462M
$328K ﹤0.01%
23,101
LAB icon
2575
Standard BioTools
LAB
$314M
$325K ﹤0.01%
82,974
-9,425
-10% -$44.1K

Similar funds

UBS AM's Q4 2021 Portfolio in Review

As of Q4 2021, UBS AM held 2,965 positions worth $261B, up 8.3% from $241B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

UBS AM's Q4 2021 filing shows 219 new, 1,218 increased, 1,020 reduced and 126 closed positions. Its largest new stake was iShares Russell Mid-Cap Value ETF: 3,293,120 shares worth $403M. The largest sale was Microsoft, an estimated $1.39B.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • UBS AM's largest Q4 2021 buy was iShares Russell Mid-Cap Value ETF: 3,293,120 shares worth $403M.
  • UBS AM added most to Shopify in Q4 2021, an estimated $873M increase.
  • UBS AM's biggest Q4 2021 reduction was Microsoft, cutting an estimated $1.39B.
  • UBS AM fully exited Baidu in Q4 2021, selling an estimated $360M.
  • UBS AM's ten largest holdings make up 22% of its $261B portfolio in Q4 2021.
  • UBS AM opened 219 new positions and closed 126 in Q4 2021.
  • UBS AM's portfolio value rose 8.3% quarter-over-quarter to $261B.

Based on UBS AM's 13F filing for Q4 2021, filed 14 Feb 2022.